Kono K - Search Results

1

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

Thura M, Al-Aidaroos AQO, Yong WP, Kono K, Gupta A, Lin YB, Mimura K, Thiery JP, Goh BC, Tan P, Soo R, Hong CW, Wang L, Lin SJ, Chen E, Rha SY, Chung HC, Li J, Nandi S, Yuen HF, Zhang SD, Guan YK, So J, Zeng Q. Thura M, et al. Among authors: kono k. JCI Insight. 2016 Jun 16;1(9):e87607. doi: 10.1172/jci.insight.87607. JCI Insight. 2016. PMID: 27699276 Free PMC article.

2

[Generation of HER2 specific, HLA-A24 restricted CTLs derived from gastric cancer patients].

Mimura K, Kono K, Sugai H, Miyagawa N, Omata H, Fujii H, Matsumoto Y. Mimura K, et al. Among authors: kono k. Gan To Kagaku Ryoho. 2003 Oct;30(11):1802-4. Gan To Kagaku Ryoho. 2003. PMID: 14619524 Japanese.

3

[Study of monocyte intracellular cytokine and heterogeneity of monocytes in a gastric cancer patient].

Sugai H, Kono K, Miyagawa N, Mimura K, Takahashi A, Fujii H, Matsumoto Y. Sugai H, et al. Among authors: kono k. Gan To Kagaku Ryoho. 2003 Oct;30(11):1844-7. Gan To Kagaku Ryoho. 2003. PMID: 14619535 Japanese.

4

Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes.

Kono K, Sato E, Naganuma H, Takahashi A, Mimura K, Nukui H, Fujii H. Kono K, et al. Clin Cancer Res. 2004 Apr 1;10(7):2538-44. doi: 10.1158/1078-0432.ccr-03-0424. Clin Cancer Res. 2004. PMID: 15073134

5

Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma.

Mimura K, Kono K, Hanawa M, Kanzaki M, Nakao A, Ooi A, Fujii H. Mimura K, et al. Among authors: kono k. Clin Cancer Res. 2005 Jul 1;11(13):4898-904. doi: 10.1158/1078-0432.CCR-04-2476. Clin Cancer Res. 2005. PMID: 16000588

6

A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.

Miyagawa N, Kono K, Mimura K, Omata H, Sugai H, Fujii H. Miyagawa N, et al. Among authors: kono k. Oncology. 2006;70(1):54-62. doi: 10.1159/000091185. Epub 2006 Jan 27. Oncology. 2006. PMID: 16446550

7

Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma.

Kawaguchi Y, Kono K, Mimura K, Sugai H, Akaike H, Fujii H. Kawaguchi Y, et al. Among authors: kono k. Int J Cancer. 2007 Feb 15;120(4):781-7. doi: 10.1002/ijc.22370. Int J Cancer. 2007. PMID: 17096332

8

Vascular endothelial growth factor partially inhibits the trastuzumab-mediated antibody-dependent cellular cytotoxicity of human monocytes.

Mimura K, Kono K, Takahashi A, Kawaguchi Y, Mizukami Y, Fujii H. Mimura K, et al. Among authors: kono k. Oncology. 2007;72(3-4):172-80. doi: 10.1159/000112803. Epub 2007 Dec 20. Oncology. 2007. PMID: 18097168

9

Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamous cell carcinoma: relation to susceptibility to perforin-granzyme.

Kawaguchi Y, Kono K, Mizukami Y, Mimura K, Fujii H. Kawaguchi Y, et al. Among authors: kono k. Anticancer Res. 2009 Jun;29(6):2137-46. Anticancer Res. 2009. PMID: 19528474 Free article.

10

Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma.

Watanabe M, Kono K, Kawaguchi Y, Mizukami Y, Mimura K, Maruyama T, Fujii H. Watanabe M, et al. Among authors: kono k. Br J Cancer. 2010 Feb 2;102(3):520-9. doi: 10.1038/sj.bjc.6605502. Epub 2009 Dec 22. Br J Cancer. 2010. PMID: 20029417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,337 results

Search Page

Filters